BORTEZOMIB, LENALIDOMIDE, AND DEXAMETHASONE (VRD) AS FIRST-LINE TREATMENT IN PATIENTS DIAGNOSED WITH MULTIPLE MYELOMA. EXPERIENCE IN NON-CANDIDATE PATIENTS FOR HEMATOPOIETIC PROGENITOR TRANSPLANTATION

HAEMATOLOGICA(2021)

引用 0|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要